# Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1

> **NCT07224035** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **University of Miami** · enrollment: 500 (estimated)

## Conditions studied

- H Pylori Infection
- H Pylori Gastritis
- Gastric Cancer

## Interventions

- **DRUG:** PYTEST® 14C-Urea Breath Test
- **DRUG:** VOQUEZNA® Triple Pak®

## Key facts

- **NCT ID:** NCT07224035
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-10-15
- **Primary completion:** 2027-11-06
- **Final completion:** 2027-11-06
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-02-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07224035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07224035, "Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07224035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*